Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Exosome multivalent vaccine - Capricor Therapeutics

Drug Profile

Exosome multivalent vaccine - Capricor Therapeutics

Alternative Names: Exosome display vaccine; Exosome-SARS-CoV-2 Display Vaccine; StealthX™ vaccine

Latest Information Update: 30 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Capricor Therapeutics
  • Class COVID-19 vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - COVID 2019 infections

Highest Development Phases

  • Phase I COVID 2019 infections

Most Recent Events

  • 13 Mar 2026 Adverse events data from a phase-I clinical trials in COVID-2019 infections released by Capricor Therapeutics
  • 11 Aug 2025 Phase-I clinical trials in COVID-2019 infections (Prevention) (IM) (prior to August 2025)
  • 11 Aug 2025 The US FDA approves the Investigational New Drug application (IND) for StealthX™ exosome-based vaccine for the prevention of COVID-2019 infections (prior to August 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top